Celgene, AbbVie extracted higher prices in Q4 as other pharmas netted less: reportadmin 3rd April 2018 Uncategorised 0
Pharma ended 2017 with prices down, not up, a new report shows. Net prices after rebates and discounts slipped 1.1% in the fourth quarter, despite list price increases of 5.5%. But some companies were able to squeeze out significant price gains—and ride those gains to sales growth.
More: Celgene, AbbVie extracted higher prices in Q4 as other pharmas netted less: report